Indian shares set for positive start on talks to end Iran war, strong Reliance earnings Reuters
Why NAII Stock dropped -4.31% Today — RQD Quant Desk Flash
Natural Alternatives International Inc. (NAII) carries a Roarable Rating of E (Strong Sell) with 34/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is NAII stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-01, Natural Alternatives International Inc. (NASDAQ: NAII) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 34/100 at a spot price of $1.11 (-4.31% 1D, market cap $6.9M). Pillar breakdown: Fundamental Cash Engine 9/20, Institutional 13F & Options Flow 4/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 5/20. Across 1016 tracked Health Care issuers, NAII ranks #855 in composite RQD confidence.
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does NAII compare to BON and MTEX in the Health Care sector?
▼
Within the Health Care sector (Medicinal Chemicals and Botanical Products), NAII carries a Roarable E (34/100 RQD), trailing P/E of N/A, gross margin of 7.2%, and ROIC of -10.8%. By comparison, BON (Bon Natural Life Limited (Class A)) holds a D grade (45/100 RQD, P/E N/A, ROIC —, cap $9.2M) and MTEX (Mannatech Incorporated) posts a E grade (33/100 RQD, P/E N/A, ROIC -35.0%, cap $16.1M). Among the 5-stock peer group, NAII leads on earnings multiple (N/A) while NAII leads on capital efficiency (-10.8% ROIC).
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for NAII?
▼
Per NAII's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-06-30, CIK 0000787253), Natural Alternatives International Inc. generated $129.9M in revenue (+14.1% YoY), -$13.6M in net income, and $2.3M in free cash flow against $153.3M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
SEC XBRL FY 2025 (10-K): 1.8% FCF Margin ($2.3M FCF) & 7.2% Gross Margin
Altman Z-Score 1.45 (DISTRESS RISK (<1.8)) • Piotroski F-Score 4/9
Put hedging (50% put share) caps near-term gamma upside (-16 pts vs max)
⚔️ Adversarial Opposing Case: What Could Spark a NAII Turnaround Squeeze
While NAII currently carries a cautious 34/100 (E) rating due to Whale & Options Positioning (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
Established market leader in Health Care with deep daily trading liquidity.
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($1.63) and Max Pain ($1.17) forces dealer call-delta covering toward $5.21.
Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.72% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
Why NAII Stock dropped -4.31% Today — RQD Quant Desk Flash
Natural Alternatives International Inc. (NAII) dropped -4.31% to $1.11, trading at 2% of its 52-week range ($1.07 – $4.96). Stretched risk/reward at current multiples (-11% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 2% of its 52-week range ($1.07 – $4.96) with RSI-14 at 25.4 (OVERSOLD (<32)).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $1.11 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable E (Strong Sell) backed by 7.2% gross margin and $2.3M annual free cash flow.
Russia's FSB says minor detained over park attack threat after US tip-off Reuters
Oil slips more than 1% as talks continue on ending Iran war Reuters
Nine people dead in Learjet crash in south Florida, officials say Reuters
Iran's IRGC Navy says two tankers 'exploded' after hitting mines in Hormuz Reuters
The market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
Haley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
Israeli strikes kill eight people in Gaza - medics say Reuters
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring NAII)
- ✓Walkthrough of NAII's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
NAII Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on NAII today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for NAII. Explore sector supply chains on /butterfly.
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (NAII)
1. Head-to-Head Health Care Peer Comparison (NAII vs. BON, MTEX, AKAN, IMCC)
Industry: Medicinal Chemicals and Botanical Products (24 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, Natural Alternatives International Inc. (NAII) ranks #855 by composite RQD confidence (34/100, grade E) and #922 by equity capitalization ($6.9M). Within this direct 5-issuer industry benchmark cohort, NAII leads on earnings valuation at N/A trailing P/E, while NAII leads on capital efficiency and profitability with -10.8% ROIC and 7.2% gross margin. IMCC currently holds the highest overall quantitative score in the immediate peer group at 64/100 (C) compared with NAII at 34/100 (E).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| NAII
ACTIVE
Natural Alternatives International Inc. | E | 34/100 | — | 7.2% | -10.8% | -4.31% | $6.9M | Benchmark Subject |
| BON Bon Natural Life Limited (Class A) | D | 45/100 | — | 20.8% | — | -0.01% | $9.2M | /bon-vs-naii → |
| MTEX Mannatech Incorporated | E | 33/100 | — | 74.9% | -35.0% | -2.23% | $16.1M | /mtex-vs-naii → |
| AKAN Akanda Corp. | D+ | 54/100 | — | — | — | +2.80% | $2.6M | /akan-vs-naii → |
| IMCC IM Cannabis Corp. | C | 64/100 | — | — | — | +3.53% | $1.5M | /imcc-vs-naii → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-06-30 • CIK 0000787253In its most recent audited fiscal period (FY2025, filed 2025-06-30), Natural Alternatives International Inc. (NAII) reported GAAP revenue of $129.9M (+14.1% vs. FY2024 revenue of $113.8M ) , GAAP net income of -$13.6M, operating cash flow of $5.9M, and free cash flow of $2.3M (+151.4% YoY). On the balance sheet, NAII closed FY2025 with $153.3M in total assets against $0 in total debt (Altman Z-Score: 1.45, Piotroski F-Score: 4/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-06-30 | $129.9M | -$13.6M | $5.9M | $2.3M | $153.3M | — |
| FY2024 (FY) | 2024-06-30 | $113.8M | -$7.2M | -$1.5M | -$4.5M | $156.1M | — |
| FY2023 (FY) | 2023-06-30 | $0 | $2.5M | $7.0M | $7.0M | — | — |
3. NAII Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs NAII stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, Natural Alternatives International Inc. (NASDAQ: NAII) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 34/100 at a spot price of $1.11 (-4.31% 1D, market cap $6.9M). Pillar breakdown: Fundamental Cash Engine 9/20, Institutional 13F & Options Flow 4/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 5/20. Across 1016 tracked Health Care issuers, NAII ranks #855 in composite RQD confidence.
How does NAII compare to BON and MTEX in the Health Care sector?
Within the Health Care sector (Medicinal Chemicals and Botanical Products), NAII carries a Roarable E (34/100 RQD), trailing P/E of N/A, gross margin of 7.2%, and ROIC of -10.8%. By comparison, BON (Bon Natural Life Limited (Class A)) holds a D grade (45/100 RQD, P/E N/A, ROIC —, cap $9.2M) and MTEX (Mannatech Incorporated) posts a E grade (33/100 RQD, P/E N/A, ROIC -35.0%, cap $16.1M). Among the 5-stock peer group, NAII leads on earnings multiple (N/A) while NAII leads on capital efficiency (-10.8% ROIC).
What are the biggest fundamental strengths and SEC risk factors for NAII?
Per NAII's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-06-30, CIK 0000787253), Natural Alternatives International Inc. generated $129.9M in revenue (+14.1% YoY), -$13.6M in net income, and $2.3M in free cash flow against $153.3M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is NAII trading relative to its 50-day, 200-day, and 52-week technical levels?
NAII last traded at $1.11 (-4.31% on volume of 38,016 shares), positioning the stock -31.90% below its 50-day simple moving average ($1.63) and -54.69% below its 200-day simple moving average ($2.45). Across its 52-week range of $1.07 to $4.96, NAII sits at the 1.0% percentile with a 14-day RSI of 25.4 (OVERSOLD (<32)) and an implied next-earnings move of ±12.5% ($1.00 to $1.25).
NAII Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is NAII stock moving today?
Why NAII Stock dropped -4.31% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-11% return on capital) under elevated 10-year interest-rate pressure.